[11C]ER-176

N/A

Report date: 2025/11/25 15:56:44
NME

Base Information

Drug Name[11C]ER-176
Drug Alias Name[11C]ER-176
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Carbon > 11CDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5] 
Mechanisms of ActionTranslocator protein modulators
TargetsTranslocator protein
Therapy Area/IndicationsAlzheimer DiseaseDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversita Di PisaUniversity Of SalernoNational Institute of Health, Islamabad
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthUniversita Degli Studi Di SalernoColumbia University +[6] 
Inactive CompaniesNational Institute Of Mental Health (Nimh)
Active IndicationsAlzheimer Disease
Inactive IndicationsDementia

Other Information

ATC CodeN/A
Related LinksN/A